Feed Insights Top Reports Pricing

⌘K

07:16:51·1595d

NEWSReleasevia Quantisnow

US Approves $2.9B In Grant For Infra Projects

ByQuantisnow·Wall Street's wire, on your screen.

PHO· Invesco Water Resources ETF

#watchlistBeagle is online

BeagleApp7:16 AM

Heads up - $PHO just hit the newswire. Here is the headline that moved it:

US Approves $2.9B In Grant For Infra Projects

Sourced from the filing - want the 30-second brief? Never financial advice.

Hire Beagle to watch $PHO

👀7🚀4🐶3

Plus alert sent

Quantisnow Plus members were alerted at 07:16:52 ET - 1.6s after publication.

Sign up for Plus

beagle.

by Alamere Labs

Now hiring

Your first full-time market-watch teammate

Market research that briefs you, before the bell.

Beagle watches $PHO across price, news, SEC filings and the macro calendar, drafts the morning brief, and pings you the moment a name moves - sourced every time, and never financial advice.

Price levelsSEC filingsBreaking newsMacro calendar

Hire Beagle See an alertLives in Slack & Teams

Free Quantisnow account

Get notified the moment PHO files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHO (Invesco Water Resources ETF) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Software Provider Roper Tech Boosts Annual Outlook Following Q1 Performance: The Details
Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN
Photocure ASA: Results for the fourth quarter of 2023
Photocure Partner Asieris Announces New Drug Application Acceptance for Regulatory Review of Hexvix in China
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022